# Max Ivermectin- COVID 19 Study Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study

> **NCT04373824** · NA · UNKNOWN · sponsor: **Max Healthcare Insititute Limited** · enrollment: 50 (estimated)

## Conditions studied

- COVID

## Interventions

- **DRUG:** Ivermectin

## Key facts

- **NCT ID:** NCT04373824
- **Lead sponsor:** Max Healthcare Insititute Limited
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-25
- **Primary completion:** 2020-07-25
- **Final completion:** 2020-07-25
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2020-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04373824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04373824, "Max Ivermectin- COVID 19 Study Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04373824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*